Volume 4, Issue 11
Corrigendump. 1056
Corrigendum: Clinical Investigation (2015) Vol 4, Iss 11.
Editorialp. 989–991
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Author(s): Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorialp. 993–996
Trials and tribulations of conducting medication trials: pediatric bipolar disorder as prototype
Author(s): Mani Pavuluri
Research Updatep. 997–1000
Standards for Research in Child Health: developing guidelines for the design, conduct and reporting of pediatric clinical trials
Author(s): Allison C Needham, Martin Offringa
Commentaryp. 1001–100
Clinical trials to prevent/treat childhood asthma: methodologic issues
Author(s): Scott T Weiss, Augusto A Litonjua
Special Reportp. 1005–101
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Author(s): Gareth J Veal
Clinical Trail Perspectivep. 1013–101
The European Union Pediatric legislation: impact on pharmaceutical research in pediatric populations
Author(s): Philippe Auby
Clinical Trail Perspectivep. 1021–103
Can we improve the efficiency of early phase trials in pediatric oncology?
Author(s): Esther Blanco & Darren Hargrave
Clinical Trail Methodologyp. 1031–104
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Author(s): Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Outcomesp. 1043–105
Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results
Author(s): Marcus R Benz, Burkhard Toenshoff & Lutz T Weber
